Overview
Biology and Therapeutic Advances for Pediatric Osteosarcoma
Microarrays
Other ArticlesGene Amplifications in Osteosarcoma—CGH Microarray Analysis
Transforming growth factor-beta 1 modulates the expression of vascular endothelial growth factor by osteoblasts High-Resolution Mapping of Amplifications and Deletions in Pediatric Osteosarcoma by Use of CGH Analysis of cDNA Microarrays
Messenger RNAExpression Levels of CXCR4 Correlatewith Metastatic Behavior and Outcome in Patients with Osteosarcoma Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalances in mouse and man Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site An Expression Signature Classifies Chemotherapy-Resistant Pediatric Osteosarcoma Terminal osteoblast differentiation, mediated by runx2 and p27 KIP1, is disrupted in osteosarcoma
Abstracts
Scientists at Broad Institute (Cambridge, MA) search Canine Osteosarcoma DNA for clues to cancer
Detection of hypothetical proteins in 10 individual human tumor cell lines
Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma
Oncogene alterations in primary, recurrent, and metastatic human bone tumors
Telomere stability genes are not mutated in osteosarcoma cell lines